Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
Not Applicable
- Conditions
- HBV CoinfectionHIV Infections
- Interventions
- Drug: efavirenz+tenofovir+lamivudine
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2011-03-18
- Lead Sponsor
- Yunnan AIDS Care Center
- Target Recruit Count
- 60
- Registration Number
- NCT01318096
- Locations
- 🇨🇳
Yunnan Provincial Hospital of Infectious Diseases/Yunnan AIDS Care Center, Kunming, Yunnan Provice, China
News
No news found